Social responsibility
We are inOphthalmic genetic diseasesThe research in the world has always received great attention and support from many patients, patients' families and all walks of life. We sincerely recognize the importance of providing help to patients and families with ophthalmic genetic diseases, and we are increasingly aware and feel that the company is focused on this industry.diagnosis and treatment planThe importance of the provider for social responsibility.
We are concerned and have found that the lack of domestic people.correctly understandOphthalmic genetic diseases,CognitionOphthalmic genetic diseasesand access to scientific behavioral guidance has led to many of the things that could have been avoided in the next generation.genetic diseaseIt continues to happen and continues to put a heavy burden on the family.
- We base ourselves on the diagnosis of genetic diseases in ophthalmology.
- Expertise and expert consultant resources in the field of prevention and gene therapy drug development
- as well as the love and dedication to social charity
- United Nations well-known universities actively into the promotion of rare diseases in ophthalmology
We hope that through our continuous efforts, we can improve the sense of identity and trust of the whole society and Chinese people for ophthalmic genetic diseases, help families of children get timely and effective assistance, and improve the clinical treatment and scientific research level of ophthalmic genetic diseases in China.
CHIGENOVO Co., Ltd. is an ophthalmic gene therapy company, a national high-tech enterprise focusing on genetic diagnosis of genetic eye diseases and the development of gene therapy drugs. It is committed to providing "one-stop" services for patients with genetic eye diseases.
HUATAO GROUP
Contact us
Telephone:400-6006223 010-82071936
Website:en.chinagene.cc
Address: Floor 4, Area D, Building 1, No.27 Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing
WeChat subscription account